Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib

BACKGROUND: Sorafenib, a kinase inhibitor active against various solid tumours, induces oxidative stress and ferroptosis, a new form of oxidative necrosis, in some cancer cells. Clinically-applicable biomarkers that reflect the impact of sorafenib on the redox metabolism of cancer cells are lacking....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Cancer
Päätekijät: Houessinon, Aline, François, Catherine, Sauzay, Chloé, Louandre, Christophe, Mongelard, Gaelle, Godin, Corinne, Bodeau, Sandra, Takahashi, Shinichiro, Saidak, Zuzana, Gutierrez, Laurent, Régimbeau, Jean-Marc, Barget, Nathalie, Barbare, Jean-Claude, Ganne, Nathalie, Chauffert, Bruno, Coriat, Romain, Galmiche, Antoine
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2016
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4894370/
https://ncbi.nlm.nih.gov/pubmed/27184800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-016-0526-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia